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The aim of this study was to assess autoimmune response
following annual influenza vaccination in apparently
healthy adults, staff at a children's hospital.
92 healthy adult subjects were tested for autoantibodies
including antinuclear antibodies (ANA), anti-extractable
nuclear antigen antibodies (anti-ENA), antiphospholipid
antibodies (aPL), namely anticardiolipin antibodies
(aCL), anti-beta2-glycoprotein I antibodies (aβ2-GPI)
and lupus anticoagulant (LA). Blood samples were taken
from each participant before annual influenza vaccina-
tion, one month and six months after vaccination.
Before influenza vaccination 26% of participants were
positive for ANA, 1% for anti-ENA, 16% for aCL, 7% for
aβ2-GPI and 2% for LA. One month after influenza vacci-
nation 76% of participants showed no change in autoan-
tibodies titres. Six months after influenza vaccination
74% of participants showed no change in autoantibodies
titres. Overall, there was no statistically significant differ-
ence in the percentage of positive ANA, aCL, aβ2-GPI and
LA before and 6 months after the vaccination. Five partic-
ipants developed autoantibodies 6 months after the vacci-
nation and one who was initially low positive for ANA
became highly positive (1:320). Eleven participants had
only transiently increased autoantibodies. Persistently
positive or progressively increased levels of autoantibod-
ies during 6 months' follow up were observed in 6 persons
(7%).
Our study showed a high percentage of positive autoanti-
body testing among healthy adult staff at a children's hos-
pital. There was no statistically significant difference in the
percentage of positive autoantibodies before and after
influenza vaccination. However, our study clearly demon-
strated induction of autoantibodies production in
selected subjects.
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